Opioid agonists, mixed agonist-antagonists and partial agonists
32,860views
00:00 / 00:00
Flashcards
Opioid agonists, mixed agonist-antagonists and partial agonists
0 of 39 complete
Questions
USMLE® Step 1 style questions USMLE
0 of 5 complete
USMLE® Step 2 style questions USMLE
0 of 8 complete
Memory Anchors and Partner Content
External References
First Aid
2024
2023
2022
2021
Acetylcholine (ACh)
opioid analgesics p. 567
Acute pulmonary edema
opiod analgesics p. 567
Adverse effects/events
opioid analgesics p. 567
Calcium channels
opioid effect on p. 567
Diarrhea
opioids for p. 567
opioid withdrawal p. 588
5-HT
opioid effects p. 567
Glutamate
opioid effects p. 567
Heroin
opioids for withdrawal p. 567
Miosis
opioids p. 568
Naloxone
for opioid toxicity p. 247, 567, 588
Naltrexone
opioid toxicity p. 567, 588
Norepinephrine (NE)
opioid effect on p. 567
Opioids p. 568
Beers criteria p. 246
intoxication and withdrawal p. 588
pentazocine and p. 568
sleep apnea p. 697
toxicity treatment p. 247
Potassium channels
opioid effect p. 567
Pregnancy p. 651
opiate use during p. 633
Pulmonary edema
opioids for p. 567
Respiratory depression
opioids p. 568
Vomiting
with opioid analgesics p. 567
External Links
Medscape
Medscape
Medscape
Medscape
Medscape
Medscape
Medscape
Medscape
Medscape
Medscape
Medscape
Medscape
Medscape
Medscape
Medscape
Medscape
Medscape
Medscape
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Wikipedia
Transcript
Content Reviewers
Contributors
Opioid agonists are medications used mainly to control acute or chronic pain in particular situations.
Some of them are also used to treat diarrhea and cough. When treating pain, the goal should be to use short-acting opioids at the lowest effective dose for just a few days, and slowly increase their dose only as needed.
As a class, opioids share one thing in common, they bind to opioid receptors in the brain, spinal cord, and gastrointestinal tract.
Some are endogenous, meaning they are produced naturally by the body, like endorphins, short for endogenous morphine.
But others are exogenous, meaning they come from outside the body, like heroin and morphine, which come from the opium poppy; a flowering plant that oozes a milky white liquid.
To understand how opioids work, let’s zoom into a region of the brain tissue that has opioid receptors.
Normally, in the absence of endorphins, inhibitory neurons secrete a neurotransmitter called gamma-aminobutyric acid, or GABA, that prevents nearby neurons from releasing neurotransmitters like dopamine, serotonin, and norepinephrine.
Now, let’s say someone goes to play a rigorous game of badminton. Exercise releases endorphins which activate the three major opioid receptors located on the inhibitory neurons, called the mu, kappa, and delta receptors.
As endorphins bind to these receptors, they block the inhibitory neuron from releasing GABA, allowing the dopamine, serotonin, and norepinephrine secreting neurons to freely unload their neurotransmitters, which then get picked up by another neuron in the same area.
Norepinephrine and serotonin release takes place in pain processing regions of the brain like the thalamus, brainstem, and spinal cord, resulting in a decreased sensitivity to pain.
When dopamine release takes place in reward pathway regions like the ventral tegmental area, nucleus accumbens, and prefrontal cortex, the result is a calming sensation that feels really good.
Summary
Opioid full agonists are drugs that bind to and activate opioid receptors in the body. They are used to treat pain and can also produce feelings of euphoria, which has led to their abuse and addiction potential. Examples of opioid agonists include morphine, codeine, and oxycodone.
Mixed agonist-antagonists bind to and activate opioid receptors to a certain extent, but also have the ability to block or inhibit the effects of other opioids. They can also be used to treat pain and may have a lower risk of abuse and addiction compared to full agonists.
Sources
- "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
- "Rang and Dale's Pharmacology" Elsevier (2019)
- "Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment" Journal of Pharmacology and Experimental Therapeutics (2019)
- "Opioid Use Disorder: Medical Treatment Options" Am Fam Physician (2019)
- "Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?" Can Fam Physician (2017)
- "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)